Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The complement membrane attack complex (MAC), also known as C5b-9, is a multi-protein complex formed on the surface of target cells. It is composed of complement proteins C5b, C6, C7, C8, and multiple copies of C9. Upon assembly, it forms a transmembrane pore, disrupting the cell membrane and leading to cell lysis. While essential for innate immunity against pathogens, its dysregulation can contribute to tissue injury in various diseases.
Pore formation leading to cell lysis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement membrane attack complex C5b-9 (MAC).